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Sonja Steinmetz1*, Andrea Tipold1, Thomas Bilzer2 and Henning Christian Schenk1Abstract
A seven-year old Australian Shepherd, suffering from idiopathic epilepsy under treatment with phenobarbitone and
potassium bromide, was presented with generalised lower motor neuron signs. Electrophysiology and muscle-nerve
biopsies revealed a neuromyopathy.
The serum bromide concentration was increased more than two-fold above the upper reference value.
Clinical signs disappeared after applying diuretics and reducing the potassium bromide dose rate. This is the first
case report describing electrophysiological and histopathological findings associated with bromide induced lower
motor neuron dysfunction in a dog.
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In veterinary medicine, potassium bromide (KBr) is
recommended as the drug of choice for treating recur-
rent generalised tonic-clonic seizures in dogs with hep-
atic insufficiency [1-3] and is frequently used as add-on
therapy [3,4]. Potassium bromide is eliminated by the
kidneys [5,6]. KBr monitoring in dogs is difficult because
KBr has a long elimination half life of 25 to 46 days
[7,8]. Side effects like general lethargy, general weakness,
decreased mentation, ataxia, paraparesis, polyphagia and
gastrointestinal affections may occur [9-14].
In dogs, also pancreatitis [15] and latency shifts in
brainstem auditory evoked response are described [16].
To the authors’ knowledge, this is the first report describ-
ing a histopathologically confirmed peripheral neuromus-
cular alteration as a suspected consequence of bromide
intoxication.Case presentation
A 7-year-old male Australian Shepherd, neutered, weigh-
ing 42 kg, treated with anti-epileptic drugs due to idio-
pathic epilepsy, was presented with a four-week history
of weakness in the pelvic limbs, progressing to the thor-
acic limbs since a few days. The last seizure episode* Correspondence: sonja.steinmetz@tiho-hannover.de
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reproduction in any medium, provided the oroccurred 10 months previously. Idiopathic epilepsy had
been diagnosed four years prior to this event by a
complete neurological assessment [normal interictal
neurological examination, complete blood cell count and
serum biochemistry, magnetic resonance imaging (MRIa)
of the brain and cisternal cerebrospinal fluid (CSF) ana-
lysis]. Anti-epileptic treatment was initiated with an ini-
tial dose of phenobarbitone 2.4 mg/kg BID PO (Luminal;
Desitin). Due to inadequate seizure control KBr was added
(10 mg/kg BID PO) by the referring veterinary surgeon.
After 10 weeks a serum bromide concentration of
16.48 μmol/l was measured (VetMedLaborb, reference
range 6–40 μmol/l). Three months later the KBr dosage
was altered to 25 mg/kg BID PO by the referring veterin-
ary surgeon attempting better seizure control. On several
occasions, the owners further increased the dosage of both
phenobarbitone and potassium bromide without contact-
ing a veterinary surgeon. Four years after the initial con-
sultation, the dog was presented at our institution for
clinical signs of generalized gait abnormalities. On presen-
tation in our clinic the dog received 4.9 mg/kg BID PO
phenobarbitone and 101.19 mg/kg SID PO KBr for almost
one year.
General physical examination revealed a severely
obese dog (42 kg). Due to adiposity it was not pos-
sible to palpate the abdomen thoroughly. The rest of
the general examination was unremarkable. Neuro-
logical examination revealed obtunded mental status,ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reactions in all limbs, reduced spinal reflexes (exten-
sor carpi radialis reflex, patellar reflex, tibialis crania-
lis reflex and flexor-withdrawal-reflex) and a bilateral
decreased menace response. Neuroanatomic localisation
was suggestive of a generalised lesion of the lower motor
neuron system. Forebrain involvement could not be
ruled out. Suspected etiological differentials included a
metabolic-toxic (e.g. hypothyroidism), neoplastic (e.g.
paraneoplastic syndrome, insulinoma), inflammatory and
also a degenerative disease (e.g. storage diseases) [17,18].
Thoracic radiographs did not reveal any abnormality.
A CBC revealed a mild leucopenia (5.7 × 109 leucocytes/l;
reference range: 6.0-12.0x109 leucocytes/l). Biochemistry
profile indicated a mild increase in glutamate dehydro-
genase (GLDH) 6.5 IU/l (reference range: 0–6 IU/l)
and alkaline phosphatase (ALP) 962 IU/l (reference
range: < 150 IU/l). Potassium and ionised calcium were
within the reference range. Thyroxine (T4) and canine
thyroid stimulating hormone (cTSH) were within nor-
mal limits (VetMedLaborb; T4: 34.75 nmol/l, reference
19–58 nmol/l; cTSH: 0.08 ng/ml, reference < 0.5 ng/ml).
The serum bromide concentration was 45 mmol/l
(ALOMEDe, reference range: 8.75-18.75 mmol/l) and
the serum phenobarbitone concentration was 168.52 μmol/l
(VetMedLaborb, reference range: 43–172 μmol/l).
Anaesthesia was induced with 0.2 mg/kg IV levo-
methadone (L-Polamivet, Veterinaria AG), 0.5 mg/kg IV
diazepam (Diazepam; Ratiopharm) and 1.2 mg/kg IV
propofol (Narcofol; CP-Pharma) and maintained with
isoflorane (Isofluran CP; CP-Pharma) in oxygen (Draeger
respiratorc). MRIa of the brain and cisternal CSF-analysis
were within normal limits, as previously diagnosed in
2005.
Electrodiagnostic examinations (Nicolet Viking Quest
IVd) were performed according to standard protocols of
our neurophysiological laboratory [19]. One side electro-
myography of the appendicular, epaxial and masticatory
muscles revealed abnormal spontaneous activity consist-
ing of mild to moderate occurrence of positive sharp
waves and fibrillation potentials in all examined muscles.
In the gastrocnemius muscle these abnormal EMGFigure 1 Myotonic discharges of the right gastrocnemius muscle.patterns occurred more pronounced and together with
occasionally recognised short episodes of myotonic
discharges (700 ms in duration) (Figure 1). Due to this
unexpected distribution pattern of abnormal activity, also
the other side of the dog was examined and revealed a
symmetrical electromyographic pattern.
Motor nerve conduction velocity was measured in both
peroneal nerves and in both radial nerves. It was impaired
in the peroneal nerves of both pelvic limbs (mNCV: left:
52 m/s; right: 56 m/s [reference: 87.7 ± 6.8 m/s] [20].
Compared to the reference values in literature [21] the
amplitudes in this patient were severely decreased (left dis-
tal stimulation 3.9 mV, left proximal stimulation 2.6 mV,
right distal stimulation 6.2 mV, right proximal stimu-
lation 3.7 mV). Furthermore the CMAP displayed a
temporal dispersion with polyphasia. In both radial
nerves the motor nerve conduction velocity was
unremarkable.
Biopsies of the left gastrocnemius muscle and peroneal
nerve were taken by standard procedures [22].Histopathology
Cryostat sections of the native gastrocnemius muscle and
the peroneal nerve were investigated after hematoxilin-
eosin staining and Gomori-trichome-staining modified
according to Engel, as well as NADH-TR/ATPase with pH
of 4.6 and 9.4 for muscle fibre type differentiation and
oil-red/black sudan and acidic phosphatase staining.
Muscle and nerve tissue samples were frozen in iso-
pentane at – 135°C and stored at −80°C until use. Read-
out of the muscle biopsy revealed a pathologically variable
fibre type spectrum including moderate fibre atrophies as
well as fibre hypertrophies. A moderate number of atro-
phic muscle fibres were of the angular type (Figures 2
and 3). Focal increase of myofibre nuclei, and of cen-
trally located nuclei, as well as endomysial and peri-
mysial fibrosis were also present. Muscle fibre type
differentiation resulted in normal, atrophic and hyper-
trophic type 1 and type 2 fibres. There were no signs
of inflammation and/or muscle fibre necrosis or
marked mitochondrial alterations (Figure 3).
Figure 2 M. gastrocnemius of the dog suffering from KBr
intoxication: pathological variation of muscle fibre caliber sizes
including neurogenic angular atrophies, moderate muscle fiber
hypertrophies (according to the 50 μm scale in the upper left
corner). Endomysial fibrosis can be identified by the pink
endomysial broadening especially in the lower part of the figure.
Cross section, hematoxilin-eosin-staining.
Figure 4 Details of the N. peroneus of the same dog suffering
from KBr intoxication. Small peripheral nerve presenting only
fragmentary myelination (arrows); variations of axonal diameters and
loss of axons can be seen; endoneural fibrosis is evident by irregular
green sectioning, as well as the increase of cell nuclei as a result of
Schwann cell proliferation. Cross section, Gomori-trichrome-staining
modified according to Engel; primary magnification: x50.
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copy. Structural changes were variable; in some of the
investigated sections the relation of the axon to the mye-
lin sheath appeared to be in a normal proportion to the
axon-diameter, but mild individual axonal swelling and
shrinking were seen. Other parts presented fragmentary
/ residual myelin, indicating a progressive demyelination
(Figure 4). Endomysial fibrosis and Schwann cell prolif-
eration were seen (Figure 4). Signs of active nerveFigure 3 Details of the M. gastrocnemius (Engel-stain): increase
in the number of muscle cell nuclei and nuclear internalisation,
endomysial fibrosis gives evidence for the chronicity of the
process (lower right quarter). Large arrows: fibre hypertrophies;
small arrows: fibre atrophies; stars: fibres with a tendency to angular
shape. No signs of mitochondriopathy producing red-stained rims in
the muscle fibres periphery. Cross section, Gomori-trichrome-staining
modified according to Engel; primary magnification: x50.regeneration or inflammation were absent. Blood vessels
showed no pathological changes. These findings were
compatible with a distinct chronic polyneuromyopathy
of metabolic / or toxic etiology.
The dog was treated with intravenous administra-
tion of 0.9% sodium chloride solution (Isotonische
Natriumchlorid-Lösung ad us. vet., B. Braun Melsun-
gen AG), furosemide 1 mg/kg IV BID (Furosemid;
Ratiopharm) and metamizol 25 mg/kg IV TID (Novalgin;
Aventis Pharma). The antiepileptic drug dosages were
reduced (phenobarbitone: initial dosage: 4.9 mg/kg BID
PO, reduced dosage: 2.38 mg/kg BID PO, potassium
bromide: initial dosage: 101,19 mg/kg SID PO, reduced
dosage: 10.12 mg/kg SID PO). The dog was discharged
after 9 days with mild gait abnormalities and an improved
neurological state. Lower motor neuron signs disappeared
completely seven days after being discharged. The serum
phenobarbitone and serum bromide concentrations were
controlled four weeks after discharge and were within
normal limits (ALOMEDe, phenobarbital 90 μmol/l, refer-
ence 65–130 μmol/l; bromide 12.39 mmol/l, reference
8.75-18.75 mmol/l). At the time of this report the dog
experiences single generalized seizures every 4–5 months.Discussion
This case report describes a dog suffering from KBr in-
toxication after KBr treatment due to uncontrolled sei-
zures. The dog presented generalized lower motor
neuron signs. Further diagnostic investigations were
consistent with a chronic neuromyopathy. This is the
first time that neuromuscular signs due to bromide
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and histopathological examinations.
In the present case axonopathy and myelinopathy were
found. However, the primary target of bromide-intoxication
could not be identified. The described patient was presented
in a chronic state of the disease. At such a time point the
initial damage (myelinopathy or axonopathy) cannot be
determined. Moreover, bromide might affect directly muscle
metabolism.
Finding the diagnosis for the presented case is challen-
ging. As already described by Arezzo et al. (2011), elec-
trophysiology and histopathology are excellent methods
to describe toxic neuropathies, although each method
has its limitation. Nerve biopsies have to be taken at
specific locations, since histopathology may be unre-
markable in proximal axons while axons in the distal
segments may reveal distal axonopathy. Electrophysi-
ology is a sensitive but not specific method. Changes
such as reduced amplitudes in evoked responses may in-
dicate structural and / or functional damage. In contrast
minor structural damage can remain undetected by elec-
trophysiological studies [23,24].
In the described case pathological spontaneous activity
occurred in the muscles of all four limbs although
marked EMG changes were particularly seen in both
gastrocnemius muscles. The histopathological affection
of both muscle fibre types indicates a neurogenic origin
of the muscle lesion. A biopsy of the tibial nerve would
have been beneficial, but due to the electrodiagnostic
findings, the peroneal nerve has been chosen. The
nerve biopsy revealed slight histopathological changes
affecting axon and myelin not correlating well with the
results of the mNCV measurements in the pelvic
limbs. These contrasting findings raise the need for a
more functional explanation of clinical signs. As brom-
ide hyperpolarizes neuronal membranes by competing
with chloride ions, the action potential generation and
propagation is reduced [16]. Already March et al.
(2002) suspected effects of bromide intoxication on
auditory evoked potential (BAER) latencies. Significant
latency shifts in waves I and V led to the assumption,
that increased serum bromide concentrations delayed
conduction along central and peripheral pathways. The
current case report supports the hypothesis that brom-
ide has a dose depending impact on the conduction in
the peripheral nervous system. Lower motor neuron
signs resolved when the bromide level declined. EMG
abnormalities were detected in all examined muscles
explaining the observed weakness in all four limbs in
the absence of a reduced mNCV in the radial nerve.
Spontaneous EMG activity seems to depend on disease
duration and degree of distribution of pathologic
mechanisms within the neuromuscular system [25].
The exclusion of other causes for the generalised lowermotor neuron signs in the described dog can addition-
ally support our theory.
Myotonic episodes observed in the gastrocnemius
muscle might also be a sign of an altered chloride conduc-
tion induced by bromide intoxication. Myotonic potentials
are often for example an electromyographic feature of
myotonia congenita [26], a disease caused by a genetic
mutation involving chloride channels. Excessive bromide
levels could influence chloride conductance in the muscle
membranes in the described dog leading to the clinical
sign of weakness.
Peripheral neuropathy is a rare finding of methyl bromide
intoxication in humans [27,28]. A dying-back axonopathy is
suspected in this toxic event.
In veterinary medicine side effects of KBr treatment
like ataxia, tremors, sedation, paresis, polyphagia, poly-
dipsia and anorexia occurring in the initial weeks of
treatment are frequently observed. Conscious proprio-
ceptive deficits, hyporeflexia and anisocoria appear in
some dogs with elevated serum bromide levels [29,30].
However, the described patient displayed lower motor
neuron signs, including a marked ambulatory tetrapar-
esis, hyporeflexia in the thoracic and pelvic limbs, as
well as sedation and conscious proprioceptive deficits.
Therapeutic drug monitoring and owner guidance are
essential in order to avoid chronic KBr accumulation
and severe side-effects [30]. In the study of Rossmeisl
and Inzana (2009) dogs with potassium bromide intoxi-
cation had lower and upper motor neuron paresis, cra-
nial nerve deficits, cerebellar ataxia and diffuse intracranial
clinical signs [31]. These studies demonstrate that
bromism can manifest as heterogeneous clinical signs
of peripheral and central nervous dysfunction. In dogs
morphological changes of the peripheral nervous system
after bromide intoxication have not been examined and
described. In this case report despite displaying histo-
pathological changes of a neurogenic myopathy, the dog
recovered completely after bromide dose reduction and
facilitated renal excretion. A bromide induced neuromyo-
pathy causing severe gait abnormalities and reduced spinal
reflexes can be suspected as a presumed clinical diagnosis
in the described dog. Other causes were ruled out and the
response to treatment supports the diagnosis. Although
phenobarbitone was reduced as well, the serum levels
were always within the reference range and the dog never
showed gait abnormalities before the add-on therapy with
KBr was initiated. However, to have evidence-based proof
that a bromide overdose was the only cause for lower
motor neuron signs another electrodiagnostic work up and
additional biopsies after clinical recovery should have been
taken. Also re-inducing the clinical signs by increasing the
dose of potassium bromide could haven proven the toxic
event. The suspected diagnosis was based on history, la-
boratory findings and repeated neurological examinations.
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fect [7,31,32] of bromide, clinical observations indicate
that signs of bromide intoxication may be present inde-
pendent of absolute serum bromide concentrations
[16,33]. A possible explanation for these findings may be
the duration of bromide therapy, slow or rapid dose
increases, breed predispositions, concurrent central or
peripheral nervous system diseases and the concurrent
use of other anti-epileptic drugs [16,31].
Conclusions
High doses of bromide may induce clinical signs of brom-
ide intoxication due to chronic accumulation. Therefore,
every six months blood parameters and bromide levels
should be evaluated routinely to rule out any changes in
serum level. Bromide intoxication may cause generalised
lower motor neuron signs, EMG and mNCV abnormal-
ities and muscle and nerve lesions which are consistent
with a neuromyopathy.
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